Correlation between a 10‐color flow cytometric measurable residual disease ( MRD ) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Correlation between a 10‐color flow cytometric measurable residual disease ( MRD ) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia

Published:2021-11-21 Issue: Volume: Page:
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Singh Jasmine¹^ORCID,Gorniak Malgorzata¹,Grigoriadis George¹²,Westerman David³,McBean Michelle³,Venn Nicola⁴,Law Tamara⁴,Sutton Rosemary⁴,Morgan Sue¹,Fleming Shaun¹²

Affiliation:

1. Laboratory Haematology Alfred Pathology Melbourne Victoria Australia

2. Clinical Haematology Monash Health Clayton Victoria Australia

3. Pathology Peter MacCallum Cancer Centre Melbourne Victoria Australia

4. Children's Cancer Institute and School of Women's and Children's Health UNSW Sydney New South Wales Australia

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.22043

Reference40 articles.

1. Australasian Cytometry Society(2020 ).ACS guideline for minimal residual disease testing.https://cytometry.org.au/resources/clinical-guidelines

2. More precisely defining risk peri‐HCT in pediatric ALL: Pre‐ vs post‐MRD measures, serial positivity, and risk modeling;Bader P.;Blood Advances,2019

3. Improved risk classification for risk‐specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL);Bassan R.;Blood,2009

4. Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics;Branford S.;British Journal of Haematology,1999

5. Standardized MRD quantification in European ALL trials: Proceedings of the second international symposium on MRD assessment in Kiel, Germany, 18‐20 September 2008;Brüggemann M.;Leukemia,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemia;Pathology;2024-10

2. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-04-30

3. Faster clinical decisions in B‐cell acute lymphoblastic leukaemia: A single flow cytometric 12‐colour tube improves diagnosis and minimal residual disease follow‐up;British Journal of Haematology;2024-03-03

4. Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year;Cancers;2023-10-19

5. Management work mode of college students based on emotional management and incentives;Frontiers in Psychology;2022-07-28